Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results

Rhea-AI Summary

Sarepta Therapeutics, Inc. (SRPT) will announce its Q4 and full-year 2023 financial results on Feb. 28, 2024. A conference call will follow to discuss the results and provide a corporate update.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report fourth quarter and full-year 2023 financial results after the Nasdaq Global Market closes on Wednesday, Feb. 28, 2024. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its fourth quarter and full-year 2023 financial results and to provide a corporate update.

The event will be webcast live under the investor relations section of Sarepta's website at https://investorrelations.sarepta.com/events-presentations and following the event a replay will be archived there for one year. Interested parties participating by phone will need to register using this online form. After registering for dial-in details, all phone participants will receive an auto-generated e-mail containing a link to the dial-in number along with a personal PIN number to use to access the event by phone.

About Sarepta Therapeutics

Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information

We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240221930450/en/

Investor Contact:

Ian Estepan, 617-274-4052

iestepan@sarepta.com

Media Contact:

Tracy Sorrentino, 617-301-8566

tsorrentino@sarepta.com

Source: Sarepta Therapeutics, Inc.

When will Sarepta Therapeutics announce its Q4 and full-year 2023 financial results?

Sarepta Therapeutics will report its Q4 and full-year 2023 financial results after the Nasdaq Global Market closes on Wednesday, Feb. 28, 2024.

What is the ticker symbol for Sarepta Therapeutics?

The ticker symbol for Sarepta Therapeutics is SRPT.

Where can interested parties listen to the conference call discussing the financial results?

Interested parties can listen to the conference call discussing the financial results on Sarepta's website at https://investorrelations.sarepta.com/events-presentations.

How long will the replay of the conference call be available for?

The replay of the conference call will be archived on Sarepta's website for one year following the event.

How can phone participants access the conference call?

Phone participants need to register using an online form to receive dial-in details and a personal PIN number to access the event.